Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Aegerion stock continues to climb after full-year financials
Bizjournals.com
Thursday, March 7, 2013 - 11:35am
tags:
Aegerion, earnings
A Deal For Pozen's PA Could Send Shares Soaring
Seeking Alpha
Thursday, March 7, 2013 - 11:34am
tags:
Pozen, GSK, vivmo, AstraZeneca
Aspen Pharmacare Offers Very Expensive Developing World Growth
Seeking Alpha
Thursday, March 7, 2013 - 11:32am
tags:
Aspen Pharmacare, GSK, JNJ, Novartis, Sanofi, South Africa
The FDA Gift That Keeps On Giving
Motley Fool
Thursday, March 7, 2013 - 11:31am
tags:
FDA, Bayer, JNJ, Xarelto
Are Antibiotics Dead Weight for Johnson & Johnson?
Motley Fool
Thursday, March 7, 2013 - 11:29am
tags:
JNJ, antibiotics
Aastrom Biosciences Finds a CEO
Motley Fool
Thursday, March 7, 2013 - 11:28am
tags:
Aastrom Biosciences
Agilent's Assays Get Kadcyla Stamp
Yahoo/Zacks
Thursday, March 7, 2013 - 11:26am
tags:
Agilent, Kadcyla, breast cancer, Genentech, assays
Amarin: Liking This Speculative Stock's Risk-Reward Ratio
Seeking Alpha
Thursday, March 7, 2013 - 11:18am
tags:
Amarin, GSK
GSK prepares to relaunch direct selling channel
Marketing Week
Wednesday, March 6, 2013 - 11:26am
tags:
GSK
Teva Pharmaceutical Industries Ltd: Today's Featured Drugs Winner
The Street
Wednesday, March 6, 2013 - 11:24am
tags:
Teva Pharmaceuticals
Reanalysis of Clinical Trial Data Confirms LipiGesic M has Robust Efficacy for Treatment of Migraine Headache and Associated Symptoms
Yahoo/PR Newswire
Wednesday, March 6, 2013 - 11:23am
tags:
LipiGesic M, Puramed Bioscience, migraines
Former Intermune CEO Loses Free Speech Appeal
Pharmalot
Wednesday, March 6, 2013 - 11:21am
tags:
InterMune, off-label, legal
Tonix Pharmaceuticals: Revolutionizing Fibromyalgia Treatment
Seeking Alpha
Wednesday, March 6, 2013 - 11:18am
tags:
Tonix Pharmaceuticals, TNX-102, fibromyalgia
Why Alexza Pharmaceuticals Ran 10% In 5 Minutes
Seeking Alpha
Wednesday, March 6, 2013 - 11:09am
tags:
Alexza
Cylene Pharmaceuticals and TetraGene Enter Agreement for Quarfloxin and Anticancer Quadruplex Technologies Agreement Includes Phase II Compound
Sacramento Bee, CA
Wednesday, March 6, 2013 - 11:08am
tags:
Cylene Pharmaceuticals, TetraGene, Quarfloxin, cancer
Teva to begin new Laquinimod Phase III trial
Globes, Israel
Wednesday, March 6, 2013 - 11:05am
tags:
Teva, laquinimod, multiple sclerosis
SJ Strategic Investments LLC announces acquisition of securities of Tribute Pharmaceuticals Inc. By SJ Strategic Investments LLC
Sacramento Bee, CA
Wednesday, March 6, 2013 - 11:02am
tags:
Tribute Pharmaceuticals
Dr. Reddy's labs launches generic Zometa in US
Pharmaceutical Business Review
Wednesday, March 6, 2013 - 11:00am
tags:
Dr Reddy's, Zometa, generics
Riboxx Pharma collaborates with CNBG to evaluate potential of Riboxxim TLR3 agonist
Pharmaceutical Business Review
Wednesday, March 6, 2013 - 10:59am
tags:
Riboxx, Riboxxim, China National Biotech Group, infectious diseases
FDA Agrees that La Jolla Pharmaceutical Has Sufficient Data for Investigational New Drug Application
San Diego Business Journal, CA
Wednesday, March 6, 2013 - 10:56am
tags:
La Jolla Pharmaceutical, LJPC-501, hepatorenal syndrome

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.